Search

Your search keyword '"Nicolas Poirier"' showing total 271 results

Search Constraints

Start Over You searched for: Author "Nicolas Poirier" Remove constraint Author: "Nicolas Poirier"
271 results on '"Nicolas Poirier"'

Search Results

1. Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings

2. Arqueo 2.0. Renovación metodológica de la prospección arqueológica de zonas de montaña

3. 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

5. 852 Modified-epitope-based vaccine (OSE2101) combined with anti-PD-1/IL-7v bispecific antibody sustains long-lasting tumor specific antigen memory T cell response in vivo

6. 1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy

7. 493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanized preclinical models

8. Sweet-inhibiting effects of gurmarin on intake during repeated acute and long-term sugar exposure: A behavioural analysis using an animal model

9. ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression

10. Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth

11. SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation

13. Archeotracker

14. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities

15. Exploiting White-Light Observations to Improve Estimates of Magnetic Connectivity

16. Les défis d’une approche multisource et diachronique de l’occupation du sol : l’exemple de la vallée de la Garonne

17. Investigating the Origin of the First Ionization Potential Effect With a Shell Turbulence Model

18. 212 CLEC-1 is a novel myeloid immune checkpoint for cancer immunotherapy limiting tumor cells phagocytosis and synergizing with tumor-targeted antibodies

19. IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates

21. Full antagonist of the IL-7 receptor suppresses chronic inflammation in non-human primate models by controlling antigen-specific memory T cells

22. Comparison of Different Signal Peptides for the Efficient Secretion of the Sweet-Tasting Plant Protein Brazzein in Pichia pastoris

23. L'utilisation des micro-drones pour la prospection archéologique à basse altitude

24. La dynamique du peuplement et des espaces agraires médiévaux en Berry : propositions pour une évaluation de l’opportunisme des sociétés anciennes

25. Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders

27. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.

29. Penser la création.

30. Constraining Global Coronal Models with Multiple Independent Observables

31. Du point à l'espace (rural) : localisation de mentions textuelles et mise à l'épreuve de normes socio-spatiales

32. First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα

36. Source and Propagation of a Streamer Blowout Coronal Mass Ejection Observed by the Parker Solar Probe

37. Investigating the Source of the Slow Solar Wind Using Solar Orbiter Observations and the IRAP Solar Atmospheric Model

40. Wild Being, between Ontology and Politics: Merleau-Ponty, Lefort, Castoriadis

41. CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy

45. P721 Treatment of Ulcerative Colitis with OSE-127 (lusvertikimab), a Strict IL-7Rα Antagonist, Non-Cytotoxic Monoclonal Antibody

46. Abstract 2955: Anti-PD-1/IL-7v bispecific antibody promotes TCF1+ stem like CD8 T cells expansion and long-lasting in vivo efficacy

47. Abstract 2957: CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis

48. Abstract 2129: Predictive response biomarkers from Phase I clinical trial of a SIRPalpha inhibitor BI765063, stand-alone and in combination with ezabenlimab, a PD1 inhibitor, in patients with advanced solid tumors

49. Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance

50. La violence du pouvoir : Elias Canetti, théoricien critique de la puissance

Catalog

Books, media, physical & digital resources